Clinical Trial Update: Dihydroartemisinin (DHA)-Piperaquine for IPT to Prevent Malaria in Children in Burkina Faso [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated dihydroartemisinin-piperaquine as intermittent preventive treatment to prevent malaria in children in Burkina Faso; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 2, Phase 3 | Status: COMPLETED